🔗 Share this article

An underground economy for unlicensed weight-loss medications is propelled by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Investigational Drug Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Followers are urged to message these profiles directly for source information, while also receiving discount codes.

Active Trade on Social Networks

Additionally, a flourishing trade exists on Telegram, where groups with numerous of participants share “before and after” images, injection guides and assertions of next-day British shipping. Vendors market the substance there before directing buyers to other platforms for transactions.

Learning About Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, physicians and chemists have warned that the distribution of what is still an unapproved drug in the UK is worrisome and could result in users injecting substances of uncertain source.

Some experts stated the popularity for retatrutide could be linked to the increasing cost of approved weight loss products such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, marketing, and consumer regulations, risking penalties, legal action or prison.

Service Reaction and Content Removal

According to TikTok, the platform has taken down problematic content and banned related hashtags and search suggestions. The company said it was committed to keeping the service secure and investing in strengthening compliance measures.

Digital Trading Operations

Investigations also discovered groups with up to nine thousand participants marketing retatrutide using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up groups with thousands of users, filled with images of weight loss, positive testimonials and step-by-step instructions for preparing or administering at home.

Within minutes of entering one community, a seller shared WhatsApp details, where most purchases occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.

Item Information and Costs

Inside these groups, messages show dark colored parcels with Royal Mail labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors usually sold at £160 for 20 milligrams. When asked how much time a injector should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service stated it actively moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting substances they cannot confirm. Even if the science behind this drug is valid, these online products may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.

Her staff has previously encountered patients harmed by self-injection from unverified suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly experimental product not yet authorized … may expose patients to possibly significant medical dangers”.